BSI-082
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BSI-082, covering 2025-09-04 to 2025-09-04. Get the full timeline:
Most recent: Clinical Trial Update: Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors [Phase 1]